Approach
| 0-12 months | >1-12 yes: Dose by weight as below | Adults (>13 yrs) |
||||
| ≤15kg | 16-23kg | 24-40kg | >40kg | |||
| Oseltamivir PO (course 5 days) | 3mg/kg/dose bd | 30mg bd | 45mg bd | 60mg bd | 75mg bd | 75mg bd |
| Zanamivir inhaled (course 5 days) |
Not licensed for use in children aged <5 years old. For children age ≥5yrs, dose : 10mg (x2 5mg inhalations) bd | 10mg (x2 5mg inhalations) bd | ||||
Links
- Clinical approach potential Adult, Paediatric 'Flu cases
- HPSC page (2016) in antivirals in 'Flu
- hpsc 2015 algorithm Mx adult patients with possible 'flu
- hpsc 2015 algorithm Mx paediatric patients with possible 'flu
- NICE recommendations (and summary) on use of antiviral agents for influenza prophylaxis
- NICE recommendations (and summary) on use of antiviral agents for influenza therapy
- Details of Influenza Activity in Ireland are available on the HPSC website
- Details of Influenza Activity in Europe are available on the EISS website
- Details of Influenza Information for Health Professionals on the HPSC website
